NASDAQ:AURA

Aura Biosciences, Inc.

Stock

USD

Last Close

5.41

06/11 21:00

Market Cap

367.12M

Beta: -

Volume Today

157.64K

Avg: 116.01K

PE Ratio

−3.16

PFCF: −5.86

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-24.20M -	-22.21M 8.24%	-35.25M 58.75%	-58.76M 66.70%	-76.41M 30.03%
depreciation and amortization	509K -	831K 63.26%	831K 0%	1.18M 41.64%	1.29M 10.03%
deferred income tax	11K -		14K -		1.04M -
stock based compensation	507K -	736K 45.17%	2.31M 213.45%	6.41M 177.94%	8.77M 36.81%
change in working capital	2.46M -	-3.68M 249.31%	-315K 91.44%	-3.10M 884.76%	-1.04M 66.47%
accounts receivables
inventory
accounts payables	1.04M -	-1.72M 265.00%	1.05M 161.24%	340K 67.74%	-1.04M 405.88%
other working capital	1.42M -	-1.96M 237.79%	-1.37M 30.08%	-3.44M 151.42%	1.04M 130.21%
other non cash items	43K -	-3K 106.98%	4K 233.33%	-325K 8,225%	2.49M 867.38%
net cash provided by operating activities	-20.67M -	-24.32M 17.69%	-32.41M 33.26%	-54.60M 68.47%	-63.85M 16.93%
investments in property plant and equipment	-2.22M -	-771K 65.29%	-2.13M 175.62%	-1.09M 48.52%	-709K 35.19%
acquisitions net				66.78K -
purchases of investments				-119.78M -	-233.65M 95.06%
sales maturities of investments				53.01M -	120.40M 127.13%
other investing activites				-66.78K -
net cash used for investing activites	-2.22M -	-771K 65.29%	-2.13M 175.62%	-67.87M 3,093.84%	-113.96M 67.92%
debt repayment	-37K -	-34K 8.11%
common stock issued	39.76M -	10.07M 74.67%	78.70M 681.50%	8.55M 89.14%	3.17M 62.92%
common stock repurchased	-13K -
dividends paid	-39.76M -
other financing activites	39.78M -	-34K 100.09%	87.56M 257,635.29%	87.08M 0.55%	94.12M 8.08%
net cash used provided by financing activities	39.73M -	10.04M 74.74%	166.26M 1,556.63%	95.63M 42.48%	97.29M 1.74%
effect of forex changes on cash
net change in cash	16.84M -	-15.06M 189.41%	131.72M 974.89%	-26.84M 120.38%	-80.52M 199.99%
cash at beginning of period	15.70M -	32.54M 107.23%	17.49M 46.26%	149.21M 753.27%	122.37M 17.99%
cash at end of period	32.54M -	17.49M 46.26%	149.21M 753.27%	122.37M 17.99%	41.85M 65.80%
operating cash flow	-20.67M -	-24.32M 17.69%	-32.41M 33.26%	-54.60M 68.47%	-63.85M 16.93%
capital expenditure	-2.22M -	-771K 65.29%	-2.13M 175.62%	-1.09M 48.52%	-709K 35.19%
free cash flow	-22.89M -	-25.09M 9.63%	-34.53M 37.63%	-55.70M 61.27%	-64.56M 15.91%

All numbers in USD (except ratios and percentages)